IRIS
BRUNETTI, JLENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.234
EU - Europa 7.035
AS - Asia 3.082
SA - Sud America 472
AF - Africa 148
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.115
IT - Italia 1.843
GB - Regno Unito 1.380
RU - Federazione Russa 1.276
CN - Cina 1.009
SG - Singapore 910
IE - Irlanda 722
SE - Svezia 397
BR - Brasile 372
VN - Vietnam 342
DE - Germania 332
FR - Francia 280
UA - Ucraina 280
HK - Hong Kong 230
KR - Corea 167
FI - Finlandia 156
IN - India 119
ZA - Sudafrica 78
ES - Italia 77
CA - Canada 64
BD - Bangladesh 61
BE - Belgio 52
PL - Polonia 51
NL - Olanda 46
AR - Argentina 38
JP - Giappone 33
MX - Messico 33
PK - Pakistan 30
TR - Turchia 29
AT - Austria 28
CH - Svizzera 25
CZ - Repubblica Ceca 24
IR - Iran 22
IQ - Iraq 21
EC - Ecuador 14
NG - Nigeria 13
AU - Australia 12
IL - Israele 12
KE - Kenya 12
PH - Filippine 12
CL - Cile 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
RO - Romania 9
AZ - Azerbaigian 8
CO - Colombia 8
DZ - Algeria 8
EG - Egitto 8
PE - Perù 8
TN - Tunisia 8
BG - Bulgaria 7
ID - Indonesia 7
KZ - Kazakistan 7
UZ - Uzbekistan 7
CI - Costa d'Avorio 6
EE - Estonia 6
PT - Portogallo 6
DK - Danimarca 5
JO - Giordania 5
SA - Arabia Saudita 5
AL - Albania 4
ET - Etiopia 4
JM - Giamaica 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
AM - Armenia 3
CR - Costa Rica 3
EU - Europa 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
PA - Panama 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
LV - Lettonia 2
MM - Myanmar 2
MY - Malesia 2
OM - Oman 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
Totale 17.973
Salva come PNG Salva come JPEG
Città #
Southend 1.208
Dallas 832
Dublin 712
Fairfield 567
Ashburn 561
Singapore 528
Chandler 402
Siena 398
Moscow 367
San Jose 365
Milan 342
Santa Clara 301
Woodbridge 277
Ann Arbor 272
Beijing 267
Houston 233
Seattle 227
Jacksonville 226
Hong Kong 214
Wilmington 202
Hefei 200
Menlo Park 171
Council Bluffs 168
Seoul 163
Cambridge 160
Rome 145
New York 142
Los Angeles 129
Florence 114
Princeton 105
The Dalles 95
Ho Chi Minh City 90
Munich 81
Johannesburg 74
Helsinki 72
Dong Ket 70
Nanjing 69
Boardman 64
Lauterbourg 63
Hanoi 60
Columbus 49
Málaga 48
Shanghai 43
San Diego 41
Fremont 37
London 37
Brussels 36
Buffalo 36
Orem 36
Bengaluru 35
Dearborn 32
Nanchang 31
San Mateo 30
São Paulo 30
Warsaw 28
Hebei 26
Atlanta 25
Tokyo 25
Figino 24
Frankfurt am Main 23
Turku 23
Washington 23
Brooklyn 22
Chicago 22
Lappeenranta 22
Shenyang 22
Bagno a Ripoli 21
Chennai 20
Naples 20
Tianjin 19
Vienna 19
Brno 18
Montreal 18
Redondo Beach 18
Stockholm 18
Turin 18
Phoenix 17
Porto Alegre 17
Toronto 17
Düsseldorf 16
Paris 15
Redwood City 15
Gdansk 14
San Francisco 14
Abuja 13
Bologna 13
Da Nang 13
Dhaka 13
Kunming 13
Manchester 13
Nuremberg 13
Rio de Janeiro 13
Denver 12
Mexico City 12
Poplar 12
Prato 12
Brasília 11
Izmir 11
Amsterdam 10
Guangzhou 10
Totale 12.050
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 383
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 374
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 372
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 371
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 370
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 367
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 352
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 346
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 335
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 332
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 318
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 317
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 316
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 314
A new NT4 peptide-based drug delivery system for cancer treatment 313
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 309
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 306
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 304
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 304
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 303
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 297
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 293
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 287
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 282
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 281
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 280
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 277
Branched peptides as bioactive molecules for drug design 271
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 264
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 261
Nanoparticles exposing neurotensin tumor-specific drivers 250
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 249
Branched peptides as targeting agents for tumor imaging and therapy 245
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 242
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 238
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 238
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 235
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 235
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 231
Branched Neurotensin peptides for tumor personalized therapy 229
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 227
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 226
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 225
A selective Nile Red based solvatochromic probe: A study of fluorescence in LUVs and GUVs model membranes 219
Light-Switchable Membrane Permeability in Giant Unilamellar Vesicles 217
The antimicrobial peptide M33. An example of drug development 216
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 215
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 214
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 213
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 210
The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly 210
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 209
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases 208
Tumor selective targeting by branched peptides 208
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 207
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 201
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 200
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells 200
The Intraflagellar Transport Protein IFT20 Recruits ATG16L1 to Early Endosomes to Promote Autophagosome Formation in T Cells 194
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 183
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 182
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 176
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 175
The antimicrobial peptide M33. An example of drug development 170
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 166
null 165
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 163
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 158
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 148
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 146
null 105
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 96
A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis 85
null 78
Editorial: Proteoglycans in the Tumor Microenvironment 77
Novel role of Hippo effector YAP1 as a rheostat controlling inflammation in dendritic cells 31
Investigating the Cytoprotective Mechanisms of the Tardigrade Damage Suppressor (Dsup) Protein in Human Cells Under Hypoxic Stress 25
Photomodulation of vesicle dynamics using fluorescent photoswitchable amphiphiles 23
Immunomodulatory and Anti-inflammatory Activity in Vitro and in Vivo of a Novel Antimicrobial Candidate 7
Totale 18.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.157 71 98 65 100 99 61 57 66 57 145 129 209
2022/20231.493 76 155 180 194 170 248 45 133 111 66 68 47
2023/20241.317 39 33 108 84 75 366 414 35 10 33 30 90
2024/20252.511 77 100 309 125 305 145 116 183 195 92 268 596
2025/20266.431 436 745 718 767 1.201 211 671 181 276 396 215 614
2026/2027229 229 0 0 0 0 0 0 0 0 0 0 0
Totale 18.269